Bipolar illness

Southern Medical Journal

Volumn 90, Issue 8, 1997, Pages 775-779

  El Mallakh, Rif S ^a,b  

^a Univ of Louisville Sch of Medicine ^*

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LITHIUM; PLACEBO; VALPROATE SEMISODIUM;

ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; ELECTROCONVULSIVE THERAPY; GENETICS; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PROGNOSIS;

BIPOLAR DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; LITHIUM COMPOUNDS; PROGNOSIS; RECURRENCE;

EID: 0030745080     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199708000-00002     Document Type: Article

References (67)

1. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
2. Feighner JP, Robins E, Guze SB, et al: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26:57-63
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition-Revised (DSM-III-R). Washington, DC, American Psychiatric Press, 1987
4. Bolton S, Gunderson JG: Distinguishing borderline personality disorder from bipolar disorder: differential diagnosis and implications. Am J Psychiatry 1996; 153:1202-1207
5. Bowden CL: The clinical approach to the differential diagnosis of bipolar disorder. Psychiatr Ann 1993; 23:57-63
6. Akiskal HS, Chen SE, Davis GC, et al: Borderline: an adjective in search of a noun. J Clin Psychiatry 1985; 46:41-48
7. Winokur G, Coryell W, Endicott J, et al: Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 1993; 150:1176-1181
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV). Washington, DC, American Psychiatric Press, 1994
9. Gelenberg AJ: Lithium efficacy and adverse effects. J Clin Psychiatry 1988; 49(suppl 11):8-9
10. Angst J: Switch from depression to mania: a record study over decades between 1920 and 1982. Psychopathology 1985; 18:140-154
11. Angst J: Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull 1987; 23:66-67
12. Himmelhoch JM, Thase ME, Mallinger AG, et al: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148:910-916
13. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36:555-559
14. Akiskal HS, Mallya G: Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23:68-73
15. Dunner DL, Russek FD, Russek B, et al: Classification of bipolar affective disorder subtypes. Compr Psychiatry 1982; 23:186-189
16. Swann AC, Secunda SK, Katz MM, et al: Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res 1986; 18:127-141
17. Post RM, Uhde TW, Roy-Byrne PP, et al: Correlates of antimanic response to carbamazepine. Psychiatry Res 1987; 21:71-83
18. Prien RF, Himmelhoch JM, Kupfer DJ: Treatment of mixed mania. J Affect Disord 1988; 15:9-15
19. Post RM: Issues in the long-term management of bipolar affective illness. Psychiatr Ann 1993; 23:86-93
20. Keller MB, Lavori PW, Coryell W, et al: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255:3138-3142
21. El-Mallakh RS: Acute lithium neurotoxicity. Psychiatr Dev 1986; 4:311-328
22. El-Mallakh RS, Kantesaria AN, Chaikovsky LI: Lithium toxicity presenting as mania. Drug Intell Clin Pharmacy 1987; 21:979-981
23. El-Mallakh RS: Lithium: Actions and Mechanisms. Washington, DC, American Psychiatric Press, 1996
24. El-Mallakh RS: Preventing bipolar relapse while avoiding lithium toxicity: the role of the lithium ratio and intraerythrocyte lithium concentration determinations. Lithium 1994; 5:17-22
25. Harrow M, Goldberg JF, Grossman LS, et al: Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 1990; 47:665-671
26. O'Connell RA, Mayo JA, Flatow L, et al: Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159:123-159
27. Vestergaard P: Treatment and prevention of mania: a Scandinavian perspective. Neuropsychopharmacology 1992; 7:249-259
28. Solomon DA, Keitner GI, Miller IW, et al: Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 1995; 56:5-13
29. Post RM, Leverich GS, Altshuler L, et al: Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 1992; 149:1727-1729
30. Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 1986; 149:191-201
31. Post RM: Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999-1010
32. Wada JA, Sato M, Corcoran ME: Persistent seizure susceptibility and recurrent spontaneous seizures in kindled cats. Epilepsia 1974; 15:465-478
33. Racine R: Kindling, the first decade. Neurosurgery 1978; 3:234-252
34. Miklowitz DL, Goldstein MJ, Nuechterlein KH, et al: Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry 1988; 45:225-231
35. Emrich HM, Dose M, von Serissen D: The use of sodium-valproate and oxycarbamazepine in patients with affective disorders. J Affect Disord 1985; 8:243-250
36. McElroy SL, Keck PE Jr, Pope HG, et al: Correlates of antimanic response to valproate. Psychopharmacol Bull 1991; 27:127-133
37. Pope HG, McElroy SL, Keck PE Jr, et al: Valproate in the treatment of acute mania: a placebo controlled study. Arch Gen Psychiatry 1991; 48:62-68
38. Freeman TW, Clothier JL, Passaglia P, et al: A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149:108-111
39. Bowden CL, Brugger AM, Swann AC, et al: Efficacy of divalproex vs lithium and placebo in treatment of mania. JAMA 1994; 271:918-924
40. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151(suppl 12):1-36
41. Dunner DL, Patrick V, Fieve RR: Rapid-cycling manic depressive patients. Compr Psychiatry 1977; 18:561-566
42. Khanna R, Gupta N, Shanker S: Course of bipolar in eastern India. J Affect Disord 1992; 24:35-41
43. Gelenberg AJ, Kane JM, Keller MB, et al: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321:1489-1493
44. Keller MB, Lavori PM, Kane JM, et al: Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992; 49:371-376
45. Puzynski S, Kosiewicz L: Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders. Psychopharmacol Bull 1984; 20:151-159
46. Hayes SG: The long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 1989; 50(suppl 3):35-39
47. McElroy SL, Keck PE Jr, Pope HG Jr, et al: The use of valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry 1989; 50(suppl 3):23-29
48. Egeland JA, Gerhard DS, Pauls DL, et al: Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 1987; 325:783-787
49. p loci and the gene for bipolar affective disorder in the Old Order Amish. Nature 1989; 342:238-243
50. Gershon ES, Goldin LR: Bipolar disorder and linkage to Xq 28. Nat Genet 1994; 7:461-462
51. Berrettini WH, Detera-Wadleigh SD, Goldin LR, et al: Genomic screening for genes predisposing to bipolar disease. Psychiatr Genet 1991; 2:191-208
52. Coon H, Jensen S, Hoff M, et al: A genome-side search for genes predisposing to manic-depression, assuming autosomal dominant inheritance. Am J Hum Genet 1993; 52:1234-1249
53. Detera-Wadleigh SD, Hsieh W-T, Berrettini WH, et al: Genetic linkage mapping for a susceptibility locus to bipolar illness: chromosomes 2, 3, 4, 7, 9, 10p, 11p, 22, and Xpter. Am J Med Genet (Neuropsychiatr Genet) 1994; 54:206-218
54. Straub RE, Lehner T, Luo Y, et al: A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet 1994; 8:291-296
55. Rutter M: Psychiatric genetics: research challenges and pathways forward. Am J Med Genet (Neuropsychiatr Genet) 1994; 54:185-198
56. Petronic A, Kennedy JL: Unstable genes - unstable mind? Am J Psychiatry 1995; 152:164-172
57. Winokur G, Coryell W, Keller M, et al: A family study of manic-depressive (bipolar I) disease: is it a distinct illness separable from primary unipolar depression? Arch Gen Psychiatry 1995; 52:367-373
58. Merikangas KR, Spiker DG: Assortative mating among inpatients with primary affective disorder. Psychol Med 1982; 12:753-764
59. McInnis MG, McMahon FJ, Chase GA, et al: Anticipation in bipolar affective disorder. Am J Hum Genet 1993; 53:385-390
60. Heun R, Maier W: The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study. Acta Psychiatr Scand 1993; 87:279-284
61. Gershon ES, Hamovit J, Guroff JJ, et al: A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982; 39:1157-1167
62. Coryell W, Endicott J, Reich T, et al: A family study of bipolar II disorder. Br J Psychiatry 1984; 145:49-54
63. Endicott J, Nee J, Andreasen N, et al: Bipolar II. combine or keep separate. J Affect Disord 1985; 8:17-28
64. Riggins GJ, Lokey LK, Chastain JL, et al: Human genes containing polymorphic trinucleotide repeats. Nat Genet 1992; 2:186-191
65. Li R, El-Mallakh RS: Triplet repeat gene sequences in neuropsychiatric diseases. Harvard Rev Psychiatry 1997 (in press)
66. Schalling M, Hudson TJ, Buetow K, et al: Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet 1993; 4:135-139
67. O'Donovan MC, Guy C, Craddock N, et al: Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet 1995; 10:380-381